This is further emphasized by the finding that a genetically determined reduction, but not lack of, sGC in the platelets of carriers of the CAD-associated risk variant rs7692387 was associated with a reduction in ANGPT1 release. This evidence concerns the gene ANGPT1 and coronary artery disorder.